Results 21 to 30 of about 205,862 (308)

Research progress of functional active peptides in the prevention and treatment of alcoholic liver injury [PDF]

open access: yesZhongguo niangzao
China is a large country of liver diseases, the popularization of anti-hepatitis virus drugs is an effective means of infectious disease prevention and treatment in China, which makes the incidence of infectious hepatitis continue to decline.
HE Linfeng, LUO Tao, WANG Cong, TANG Wendi
doaj   +1 more source

Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases

open access: yesLiver Research, 2018
Fatty liver diseases, non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) are the most common causes of chronic liver diseases around the world.
Akiko Eguchi, Ariel E. Feldstein
doaj   +1 more source

Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases [PDF]

open access: yesEndocrinology and Metabolism, 2019
The signaling network of the mitochondrial unfolded protein response (UPRmt) and mitohormesis is a retrograde signaling pathway through which mitochondria-to-nucleus communication occurs in organisms. Recently, it has been shown that the UPRmt is closely
Hyon-Seung Yi
doaj   +1 more source

Rodent models of fatty liver diseases

open access: yesLiver Research, 2018
Fatty liver diseases including alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are leading causes of chronic liver diseases worldwide.
Adeline Bertola
doaj   +1 more source

Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis [PDF]

open access: yes, 2019
Importance: Changes in the characteristics of patients with cirrhosis are likely to affect future outcomes and are important to understand in planning for the care of this population.
Chalasani, Naga   +6 more
core   +1 more source

Specificities of lipotoxicity of free fatty acids and cytokine profile in patients with chronic diffuse liver diseases

open access: yesRegulatory Mechanisms in Biosystems, 2021
Non-alcoholic fatty liver disease is an important cause of global liver disease characterized by diffuse hepatocytes with hepatocellular ballooning, intrahepatic inflammation and progressive fibrosis.
V. I. Didenko   +4 more
doaj   +1 more source

Clinical features of alcoholic hepatitis in latinos and caucasians: A single center experience. [PDF]

open access: yes, 2017
AimTo study differences of presentation, management, and prognosis of alcoholic hepatitis in Latinos compared to Caucasians.MethodsWe retrospectively screened 876 charts of Caucasian and Latino patients who were evaluated at University of California ...
Durbin-Johnson, Blythe   +3 more
core   +1 more source

High serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases

open access: yesGastroenterology Review, 2017
Introduction : N-terminal propeptide of procollagen type III (PIIINP) is generated during the synthesis of type III collagen. PIIINP can be measured in the serum as an indicator of liver fibrosis and cirrhosis.
Monika Gudowska   +7 more
doaj   +1 more source

Risk of liver dysfunction and non-alcoholic fatty liver diseases in people with hidradenitis suppurativa: A systematic review and meta-analysis of real-world evidences

open access: yesFrontiers in Immunology, 2022
BackgroundTo date, evidences with high evidence-level evaluating the association between liver diseases and hidradenitis suppurativa was lacking. Given that inconsistency exists in some of the previous observational studies, evaluating the prevalence of ...
Shuo-Yan Gau   +10 more
doaj   +1 more source

Ferroptosis in Chronic Liver Diseases: Opportunities and Challenges

open access: yesFrontiers in Molecular Biosciences, 2022
Ferroptosis, an iron-dependent non-apoptotic cell death characterized by lipid peroxidation, is a cell death pathway discovered in recent years. Ferroptosis plays an important role in tumors, ischemia-reperfusion injury, neurological diseases, blood ...
Xiaoxi Zhou   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy